DOCGO INC

DCGONASDAQ

🏆 #3835 by market capUS Equity

$0.64▲ $0.07 (+10.77%)

Live

1h▲ 7.5%

24h▲ 10.8%

7d▲ 3.5%

14d▼ 0.9%

30d▼ 1.3%

1y▼ 61.2%

🏦Market Cap

$64M

Small Cap

📈Revenue Growth (YoY)

-42.0%

Declining

📊Gross Margin

30.4%

Moderate

💵FCF Margin

17.2%

Healthy

⚖️P/S Ratio

0.2x

Cheap

Otter Score

Fair

Trading Snapshot

Day Range: $0.64 – $0.65
52-Week Range: $0.45 – $1.78
Volume: $5.31B
Avg Volume: $5.00B
Shares Outstanding: 98.8M
Next Earnings: Sep 28, 2026

Fundamentals Snapshot

Annual Revenue: $322M
Last Q Revenue: $76M
P/E Ratio: —
P/S Ratio: 0.2x
EPS (TTM): $-1.91
Dividend Yield: —

Why Investors Own DCGO

✓High-growth profile — revenue up +39.7% YoY with expanding US Equity exposure.
✓Healthy economics — 35% gross margin and 28% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$322M▲ +41.4% YoY

Gross Margin (TTM)

34.8%▼ −0.5% YoY

Operating Income (TTM)

$99M▲ +41.4% YoY

Free Cash Flow (TTM)

$89M▲ +41.4% YoY

About DOCGO INC

DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.

🦦